SUPERNUS PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of S49 for the last quarter is 133.13 M EUR, and it's 10.58% lower compared to the previous quarter. The net income of Q1 24 is 114.92 k EUR.